Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor.
[ Location map ]
Phone: 603-7841 3200
Fax: 603-7968 2222
You are here
Guideline on Proposal Submission for Patient Access Scheme (PASc) Implementation in Ministry of Health
This guideline describe the process the Pharmacy Practice & Development Division, Ministry of Health uses to advise on the submission of Patient Access Scheme (PASc) proposal.
Patient Access Scheme (PASc) is a scheme proposed by pharmaceutical companies and agreed upon by the Ministry of Health (MOH), Malaysia in order to improve access to medicines which are likely to have high budget impact either due to high treatment cost per patient and/or large volumes of use. This scheme involves innovative pricing agreements designed to improve cost effectiveness and facilitate patient access to specific medicines. This scheme may address the rising cost pressure, consumer demands and uncertainties, while attempting to provide patient access to innovative care within finite budgets.
This guideline set out the process for the submission, evaluation and approval of PASc in MOH health facilities. The main part of this guideline is written for pharmaceutical companies who intend to propose PASc for medicines to be used within MOH health facilities. These requirements are designed to standardise submissions by pharmaceutical companies and minimise variability in the quality of proposals submitted.
Pharmaceutical companies who intend to propose a PASc to be implemented in MOH facilities can submit the application starting from 1stJune 2018. All PASc application forms should be sent to:
Director Pharmacy Practice and Development Division, Ministry of Health Malaysia Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor. (Att: MOH Medicines Formulary Secretariat)
Any inquiries or concerns regarding PASc application process can be forwarded to PASc Secretariat via email: email@example.com
|Patient Access Scheme (PASc) Proposal Submission Guideline||1.34 MB|